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Abstract
Background:  To compare the frequency of Y-chromosome microdeletions in Japanese and
African azoospermic and oligozoospermic men and describe embryo characteristics and
reproductive outcome following in vitro fertilization (IVF) with intracytoplasmic sperm injection
(ICSI).
Methods: Our study was performed prospectively at two centers, a private IVF clinic and a
university hospital. Japanese and African (Tanzanian) men with nonobstructive azoospermia (NOA)
and oligozoospermia (concentration < 5 × 106  /ml) were evaluated for Y-chromosome
microdeletions (n = 162). Of the 47 men with NOA, 26 were Japanese and 21 were Africans. Of
the 115 men with oligozoospermia, 87 were Japanese and 28 were Africans. Reproductive
outcomes of patients with Y-chromosome microdeletions were then compared with those of 19
IVF+ICSI cycles performed on couples with Y-chromosome intact males/tubal factor infertility
which served as a control group.
Results: Seven azoospermic and oligozoospermic patients had Y-chromosome deletions; the total
number of deletions in the AZFc region was five. There was only one deletion in the AZFa region
and one complete deletion involving all three regions (AZFa, b, and c) within AZF. In our study
population, microdeletion frequency among Japanese men was 6.2% (95% CI, 4.25% – 14.45%),
whereas no deletions were identified in the African group (95% CI, 0.0% – 7.27%). The difference
between the two groups was not statistically significant, however. Embryos derived from ICSI
utilizing sperm with Y-chromosome microdeletion showed reduced rates of fertilization, blastocyst
development, implantation, and pregnancy compared to the Y-chromosome intact group, although
these observed differences were not statistically significant.
Conclusion: The observed frequency of Y-chromosome microdeletion was 6.2% among Japanese
azoospermic and oligozoospermic males; no microdeletions were identified among our African
study patients. In this population of couples undergoing IVF+ICSI, there was no statistically
significant difference in embryo characteristics or pregnancy outcome between patients with Y-
chromosome microdeletion and those with an intact Y-chromosome.
Published: 29 June 2005
Journal of Experimental & Clinical Assisted Reproduction 2005, 2:9 doi:10.1186/
1743-1050-2-9
Received: 15 September 2004
Accepted: 29 June 2005
This article is available from: http://www.jexpclinassistreprod.com/content/2/1/9
© 2005 Kihaile et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Experimental & Clinical Assisted Reproduction 2005, 2:9 http://www.jexpclinassistreprod.com/content/2/1/9
Page 2 of 7
(page number not for citation purposes)
Introduction
Approximately15% of the couples worldwide cannot con-
ceive after one year of regular sexual intercourse, with the
male factor accounting for ~40% of all infertility; how-
ever, in up to 30% of cases the etiology is unexplained
[1,2]. Among these unknown cases of infertility, a genetic
etiology for male infertility was long suspected. This was
due to cytogenic evidence showing that 0.2% of azoosper-
mic men, who were otherwise phenotypically normal,
exhibited Y-chromosome microdeletions [3]. This evi-
dence was supported by karyotyping which revealed auto-
somal translocations in 1.3% of infertile couples [4-7].
Researchers realized that many cases of male infertility
might be genetic because of the failure of most clinical
treatments to correct abnormal sperm parameters [8,9].
Observations of sperm counts in various species, includ-
ing studies of naturally occurring deletions in drosophila
via molecular analysis, also led to an intense search for
human spermatogenesis gene(s) which might be deficient
in some infertile males [10-13]. Recent advancements in
molecular methodology have permitted careful mapping
of Y-chromosome microdeletions in men with azoosper-
mia and oligozoospermia; in Western populations this
frequency varies between 1–35%, depending on inclusion
criteria [14]. For Japanese males, a Y-chromosome micro-
deletion frequency range of 7.6–17% has been reported
[15-22]. Such studies have identified three "azoospermic
factor" regions (AZF) where deletions occur on the Y-
chromosome long arm: AZFa, AZFb, and AZFc. AZFc was
shown to contain the most frequently deleted gene clus-
ter, known as the DAZ gene [23]. Several studies found
AZFc deletions to be associated with successful retrieval of
sperm during testicular sperm extraction (TESE), whereas
deletions in AZFa and AZFb were not [23-25]. Histologi-
cally, these deletions are associated with various sperma-
togenetic alterations including Sertoli cell-only syndrome
(SCOS), maturation arrest, and hypospermatogenesis.
Recently, several investigators have shown that embryo
characteristics following intracytoplasmic sperm injection
(ICSI) using sperm obtained from men with Y-chromo-
some microdeletions were not adversely affected by the
deletion [26-31]. The central concern was that vertical
transmission of the microdeletion via ICSI might be
passed from father to son [32] or by natural (unassisted)
conception [30,33]. Since very few studies concerning Y-
chromosome microdeletion have been undertaken in Jap-
anese males (and none in African males), we aimed to
investigate the frequency of Y-chromosome microdele-
tion as well as selected embryo features and reproductive
outcome in Japanese and African azoospermic and oligo-
zoospermic men who underwent IVF+ICSI.
Materials and Methods
Between January 1998 and January 2003, male volunteers
(n = 162) presenting for infertility evaluation and treat-
ment at two centers were evaluated for Y-chromosome
microdeletions via peripheral venipuncture. The study
population consisted exclusively of Japanese (n = 113)
and African (n  = 49) males who, with their partners,
sought infertility treatment either at St. Luke IVF Center
(Japan) or Muhimbili National Hospital (Tanzania).
Written informed consent was obtained from all study
patients and the investigation was approved by the hospi-
tal's ethical committee. Subjects were partitioned into two
groups based on sperm concentration: 1) nonobstructive
azoospermia (NOA), and 2) oligozoospermia, defined as
sperm concentration < 5 × 106 ml.
The first group consisted of 47 males (26 Japanese and 21
Africans); the second group consisted of 115 males (87
Japanese and 28 Africans). None of the study patients
were diagnosed with obstructive azoospermia. Six couples
from the Muhimbili center were excluded from the study
due to active STD. The GFX Genomic Blood DNA Purifi-
cation Kit (Amersham Biosciences, Buckinghamshire,
United Kingdom) was used to extract DNA from periph-
eral venipuncture samples as previously described [34]. Y-
chromosome microdeletions were detected using a
polymerase chain reaction (PCR) amplification with a
specific sequence tag site (STS) using 24 sets of primers
which allowed evaluation of the following sites: sY14,
sY18, sY78, sY81, sY83, sY85, sY84, sY90, sY100, sY131,
sY134, sY139, sY145, sY143, sY153, sY147, sY156, sY149,
sY254, sY157, sY202, sY243, sY158, and sY159. Deletion
of the loci was confirmed if the product of the expected
size was not obtained after three single STS PCR
experiments.
Four patients with NOA and Y-chromosome microdele-
tion underwent TESE. The samples were microscopically
examined to search for sperm, which was cryopreserved as
described previously [24]. TESE was successful in 2 of 4
azoospermic cases; after cryopreservation these couples
subsequently underwent two ICSI cycles. The three Japa-
nese oligozoospermic patients with Y-chromosome
microdeletion produced fresh ejaculated sperm which
was subsequently used for 6 ICSI cycles. Sperm morphol-
ogy in each laboratory was examined by 2 observers [35];
classification of normal sperm morphology at our centers
is: <4% = severe teratozoospermia, 4–14% = moderate ter-
atozoospermia and >14% = normal. No fathers or broth-
ers of our male patients were available for testing. All
Japanese couples who had a multifactoral diagnosis of oli-
gozoospermia and tubal factor infertility were also
assessed for Y-chromosome microdeletions and those
found to have an intact Y-chromosome were assigned to
the control group. Fourteen Japanese couples wereJournal of Experimental & Clinical Assisted Reproduction 2005, 2:9 http://www.jexpclinassistreprod.com/content/2/1/9
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initially considered for this group, but three were
excluded because of endometriosis (n = 2) and leiomy-
oma (n = 1). These remaining couples (n = 11) constituted
the control group and they underwent 19 ICSI cycles. Pos-
itive and negative controls were used for all AZF microde-
letion tests. Thirteen fertile men with a sperm
concentration of >20 × 106 /ml were used as positive con-
trols, and twelve females served as negative controls.
Ovarian stimulation protocol, oocyte handling, labora-
tory procedures for insemination, measurement of sperm
parameters, hormones, ICSI, and embryo and blastocyst
grading were performed as previously described [35].
Using this protocol, only types I, II and III embryos were
considered suitable for transfer and ≤ 3 embryos were
transferred on day 3 after microinjection. For 6 cycles,
embryos were cultured until day 5–6 and were transferred
at the blastocyst stage. Clinical pregnancy was confirmed
at 6 weeks via transvaginal ultrasound to establish embry-
onic cardiac activity.
Data were analyzed for equality of variance using the Lev-
ene's test. When p > 0.05 the variances were considered
equal, a Student's t-test was performed, and p < 0.05 was
considered significant. When p < 0.05, then the variances
were considered unequal and a Wilcoxon signed ranked
test was done, and p < 0.05 was considered significant. All
computations were conducted using the SPSS statistical
package (SPSS Inc., Chicago, USA).
Results
Of 162 azoospermic and oligozoospermic Japanese and
African males who participated in the study, 47 were diag-
nosed with NOA and 115 as oligozoospermic. Of 47 NOA
cases, 26 were Japanese and 21 were Africans. Of 115 oli-
gozoospermic cases, 87 were Japanese and 28 were Afri-
can. We identified seven cases with microdeletions and
they were all within the azoospermia and oligozoosper-
mia Japanese group. Five of these deletions were identi-
fied in the AZFc region, whereas only one deletion was
identified in the AZFa region. There was also one com-
plete deletion involving all three regions of AZF (AZFa, b,
c). Therefore, the microdeletion frequency within the Jap-
anese group was 6.2% (95% CI, 4.25% – 14.45%). No
deletions were identified within the African group (95%
CI, 0.0% – 7.27%); this difference was not statistically sig-
nificant. The deletion frequency among azoospermic Jap-
anese males was 15.4% (95% CI, 11.0% – 42.0%)
whereas there were none among the African males
(95%CI, 0.0% – 15.4%). Again, the difference did not
reach statistical significance. The deletion frequency in
oligozoospermic Japanese was 3.4% (95% CI, 1.18% –
9.6%) and there were none in oligozoospermic African
males (95% CI, 0.0% – 12.0%); also with no statistical
difference.
Two patients were diagnosed with SCOS and both exhib-
ited one microdeletion in the AZFa and AZFabc regions.
(Table 2). These two patients had characteristically high
serum FSH levels (mean = 30.4 U/L, normal is < 10.0 U/L
in our laboratory). Testicular volumes of males with Y-
chromosome microdeletion and those with an intact Y-
chromosome showed no statistically significant difference
(average ± SD volumes were 11.14 ± 2.41 and 12.4 ± 3.40
ml, respectively).
Table 3 summarizes comparisons among various parame-
ters in patients with and without Y-chromosome microde-
letion. As expected, sperm concentration was significantly
lower in the Y-chromosome microdeletion group than in
the intact Y-chromosome group (p < 0.05).
Table 4 presents a comparison of embryo characteristics
observed in AZFc microdeletion and Y-chromosome
intact patients. Although the Y-chromosome microdele-
tion group showed a trend towards reduced rates of ferti-
lization, implantation, and pregnancy when compared to
the Y-chromosome intact group, this difference did not
reach statistical significance. Screening for Y-chromosome
microdeletions among our study patients' male offspring
was not conducted in this investigation.
Discussion
This study shows the frequency of microdeletion in the
AZF region of the Y-chromosome to be 6.2% among Jap-
anese males with azoospermia and oligozoospermia. Our
findings are consistent with prior reports which found a
microdeletion frequency of 1% to 35%, depending on the
male subfertility definition used for inclusion and on the
choice of sequence tagged sites used for screening
[6,14,28,36,37]. In our populaton, the majority of Y-chro-
mosome microdeletions (~70%) occurred in the AZFc
region of the AZF region and is in agreement with other
investigations [27,38]. Previous studies on Y-chromo-
some microdeletion frequency in Japanese males [15-22]
suggested a range of 7.6% – 17.0%. Separating these Jap-
anese patients with deletions into azoospermic and oligo-
zoospermic cases revealed frequencies of 15.4 % and
3.4%, respectively.
We excluded from analysis two study patients with Y-
chromosome microdeletions at sY202 and sY243. Indeed,
no known location has been ascertained so far for sY202
and sY243 is found in several locations both inside and
outside DAZ. Nevertheless, the frequency observed in our
population is consistent with previous data describing a
15%-20% microdeletion frequency in men with idio-
pathic azoospermia and a 7%-10% frequency in men with
severe idiopathic oligozoospermia [15,23,38,39]. Inter-
estingly, no microdeletions were documented among the
49 African males with azoospermia or severeJournal of Experimental & Clinical Assisted Reproduction 2005, 2:9 http://www.jexpclinassistreprod.com/content/2/1/9
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oligozoospermia. Since ours is the first study of Y-chro-
mosome microdeletion frequency to be undertaken on an
African population, a comparison with earlier data sets
from this group was not possible.
The absence of Y-chromosome microdeletions in our Afri-
can study population may be due to limited sampling.
However, this finding is in general agreement with the few
studies conducted in other parts of Africa that found fre-
quencies of male infertility secondary to oligozoospermia
or azoospermia to be much lower (~20%) in Africa than
elsewhere [40-48]. Unlike some other regions, the most
common cause of male infertility in Africa was found to
be infection. Yeboah et al. reported on 595 infertile Afri-
can males and found ~70% of them to have inflammatory
testicular lesion due to STD [40]. A multi-center study by
Cates et al. demonstrated that >50% of African couples
had secondary infertility due to STD [41], which was a rate
much higher than in non-African countries (i.e., <30%).
In our study all active STD cases were excluded, although
the association between male infertility and STD remains
controversial. Some investigators have shown that treat-
ment of infection directly improved the sperm quality in
oligozoospermia [42,43] while others did not see any
improvement in sperm quality after treatment [44,45]. It
is difficult to know the precise frequency of azoospermia
and oligozoospermia in Africa as certain cultural factors
(e.g., polygamy) are more common than in other parts of
the world [46]. Therefore, an azoospermic man may have
children whose actual biological father was another man
if the wife had extramarital intersourse with a fertile male
[47,48]. Financial constraints did not enable testing to
confirm paternity when babies were born after infertility
treatments at our centers.
All 5 cases with Y-chromosome microdeletion in the AZFc
region had successful outcomes following IVF+ ICSI. A
comparison of reproductive outcomes between couples
with AZFc microdeletion and couples with an intact Y-
chromosome showed no statistically significant differ-
ence. Our results confirm previous studies showing that Y-
chromosome microdeletions do not appear to adversely
affect fertilization and pregnancy rates (either in
azoospermic or severe oligozoospermic men) when
sperm are successfully retrieved [26-33,36]. The concerns
that IVF+ICSI might yield poorer results in the setting of
Y-chromosome microdeletions were not seen in previous
reports [26-30]. However, Van Volde et al. [29] found fer-
tilization and embryo quality to be significantly lower in
Table 1: STS markers of the 7 infertile men with Y chromosome deletions.
STS Region
Markers 1.1 1.2 1.5 1.6 1.7 1.8 1.9
s Y 1 4 +++++++
s Y 1 8 +++++++
s Y 7 8 +++++++
s Y 8 1 A Z F a - -+++++
s Y 8 3 - -+++++
s Y 8 5 - -+++++
s Y 8 4 - -+++++
s Y 9 0 - -+++++
s Y 1 0 0A Z F b +-+++++
s Y 1 3 1 +-+++++
s Y 1 3 4 +-+++++
s Y 1 3 9 +-+++++
s Y 1 4 5 +-+++++
s Y 1 4 3 ++++++
s Y 1 5 3 A Z F c +------
s Y 1 4 7 +------
s Y 1 5 6 +------
s Y 1 4 9 +------
s Y 2 5 4 +------
s Y 1 5 7 +------
s Y 2 0 2 +------
s Y 2 4 3 +------
s Y 1 5 8 +-+++++
s Y 1 5 9 +-+++++Journal of Experimental & Clinical Assisted Reproduction 2005, 2:9 http://www.jexpclinassistreprod.com/content/2/1/9
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Table 2: Findings in 7 infertile men with Y chromosome microdeletion
Patient Nos.
1.1 1.2 1.5 1.6 1.7 1.8 1.9
Left/right testis volume (ml) 9&14 12&14 14&15 13&15 9&8 13&14 8&7
sperm conc (× 106 /ml) 0 0 0 0.9 0.6 1.5 0
Deleted AZF regions a a, b, c c c c c c
FSH (U/ml) 29.5 31.3 10.3 11.6 9.1 12.7 14.3
Testicular histology SCOS SCOS MA ND ND ND MA
Sperm testicular recovery 0 0 + ND ND ND +
ND = Not done; MA = Maturation Arrest; SCOS = Sertoli cell only syndrome
Table 3: Results of the various parameters of ejaculate sperm cycles in patients with AZFc region Y-deleted and Y-Intact 
chromosomes.
AZFc region
Y-deleted Chromosome Y-Intact Chromosome Significance
Total No. Patients 5 11
Total No. Cycles 8 19
Female Age (mean) 30.9 ± 6.2 30.4 ± 5.7 NS
Duration of infertility in years (mean) 4.9 ± 3.1(2–10) 4.4 ± 2.7(2–6)
Peak E2 pg/dl (mean) 3613 ± 1876 3785 ± 1543 NS
Embryos Transferred (average)) 2.7(2–3) 2.8 (2–4) NS
Sperm Normal Morphology (%) 2.3 ± 0.5% 3.4 ± 0.7 NS
Sperm Concentration (× 106/mL) 1.5 ± 1.1 4.3 ± 1.2 p < 0.05
Motility (%) 35 ± 14.7 41 ± 11.4 NS
Table 4: ICSI attempts in 8 cycles with Y-chromosome microdeletions and 19 cycles without microdeletions.
Y-deleted Y-Intact
Chromosome Chromosome Significance
No cycles with ejaculated sperm 6 19 NS
No. cycles with Testicular sperm 2 0
Total No. oocytes 108 269 NS
Average No.oocytes (n) 13.5 ± 2.7 12.8 ± 3.5 NS
Fertilization rate(%) 60.1 ± 17.9% 71.6 ± 15.7% NS
Cleavage rate (%) 87.6 ± 14.5 85.1 ± 9.4 NS
Embryo grade 1 & II on day 3/cleaved embryos 51.70% 59.60% NS
≥6 cells embryos on day 3/cleaved embryos (%) 75.00% 72.9 NS
Blastocyts on day 5&6 /cleaved embryos (%) 50.00% 53.40% NS
Canceled cycle(s) 1 0 NS
Average mixed embryo & blastocyst ET 2.7 ± 0.5 2.8 ± 0.9 NS
Pregnancy 3 (37.5%) 9 (42.9) NS
Implantation rate 13.5 16.9 NSJournal of Experimental & Clinical Assisted Reproduction 2005, 2:9 http://www.jexpclinassistreprod.com/content/2/1/9
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couples with Y-chromosome microdeletions compared to
couples without Y-chromosome microdeletions; preg-
nancy and take home baby rates were not statistically
different.
In conclusion, our investigation did not detect any Y-chro-
mosome microdeletions in azoospermic or severely oligo-
zoospermic men of African origin. This was in contrast to
seven cases of Y-chromosome microdeletion identified in
Japanese males. Furthermore, comparison of embryo
characteristics in Japanese couples with Y-chromosome
microdeletion and control couples (those with no Y-chro-
mosome microdeletion) revealed no statistically signifi-
cant difference. We regard it as premature to conclude
definitively that Y-chromosome microdeletion in
azoospermic and oligozoospermic African males is not as
common as in other races, due to limited sampling. We
hope to continue this investigations with a larger patient
population to provide additional information on the
overall frequency of azoospermia/oligozoospermia in
African males, as well as the association of these condi-
tions with Y-chromosome microdeletions.
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